EP3362055
SGLT-2 INHIBITOR FOR USE IN THE TREATMENT OF A METABOLIC MYOPATHY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
13.10.2016EP published:
18.1.2023EP application number:
16781135.5
EPO information:
European Patent Register
Max expiry date:
12.10.2036
Title in English:
SGLT-2 INHIBITOR FOR USE IN THE TREATMENT OF A METABOLIC MYOPATHYLanguage of the patent:
English
Timeline
Today
13.10.2016EP application
18.1.2023EP Publication
Owner
Name:
Boehringer Ingelheim International GmbHAddress:
Binger Strasse 173, 55216 Ingelheim am Rhein, DE
Inventor
Name:
MAYOUX, Eric WilliamsAddress:
55216 Ingelheim Am Rhein, DE
Priority
Number:
201562242030 PDate:
15.10.2015Country:
US
Number:
201662347747 PDate:
9.6.2016Country:
US
Classification
Categories:
A61K 31/00, A61K 31/7048, A61P 21/00